Progenity, Inc. (PROG)
|Net Income (ttm)||-230.07M|
|Day's Range||2.64 - 3.05|
|52-Week Range||0.66 - 7.86|
|Price Target||3.00 (+9.9%)|
|Earnings Date||Nov 10, 2021|
Progenity, Inc., a biotechnology company, provides develops and commercializes molecular testing products in the United States. It offers Innatal, a noninvasive prenatal screening test offered to women early in pregnancy to screen for chromosome abnormalities, such as down syndrome, trisomy 18, trisomy 13, and sex chromosome disorders through the analysis of cell-free DNA; Preparent that screens for carrier status of hereditary diseases prior to or early in pregnancy; and Riscover, a hereditary cancer screen that analyzes 31 genes associated wi... [Read more...]
Financial PerformanceFinancial Statements
According to 5 analysts, the average rating for Progenity stock is "Strong Buy." The 12-month stock price forecast is 3.00, which is an increase of 9.89% from the latest price.
SAN DIEGO, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the fields of gastrointestinal health and oral biotherapeutics, today announced a new p...
The biotech has given investors a bumpy ride this month.
Unique delivery of GI-disease treatments -- along with multiple liquidity infusions -- should help to ease the concerns of PROG stock holders. The post Capital Raises Add Confidence to Fast-Moving Biote...
Before you close the books on 2021, if you hold a position in any of these seven penny stocks to sell, make sure to make your exit. Camber Energy (NYSEAMERICAN:CEI) Clover Health (NASDAQ:CLOV) Express (...
Shares of penny stock PROG are on the move and here's what's going on. The post Hot Penny Stocks Today: Why Is PROG Stock Moving?
Company received more than $44 million in warrant exercises since August 2021.
Short squeeze penny stocks to watch today. The post Best Penny Stocks To Buy For A Short Squeeze?
5 Short Squeeze Candidates For The Week: AGC SPAC Rejoins, Digital Ally, Tattooed Chef Join Leaderboard
Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next GameStop Corp (NYSE: GME) or AMC Entertainment Holdings Inc (NYSE: AMC). A short squeeze can occur wh...
Here's three penny stocks to add to your watchlist right now The post Top Penny Stocks to Add to Your Watchlist in Late November appeared first on Penny Stocks to Buy, Picks, News and Information | Penn...
Thinking of investing in penny stocks? Here's three to check out The post Investing in Penny Stocks?
One of the many recent IPOs since the Covid-19 pandemic, PROG stock has encountered numerous setbacks to be a comfortable ride. With their partnership with Avero Diagnotics, management is currently refo...
PROG stock has had its fair share of ups and downs. With a major executive-level change, however, Progenity looked poised for progress.
Shares of the biotech stock rose more than $1.50 per share Tuesday morning.
Popular short play Progenity is enjoying a good week. PROG stock is gaining as investors continue to bet against short sellers.
Progenity came public as a genetic testing company in 2020, then closed the lab and is doing early-stage clinical trials. The post With Progenity, What Is Pumped Will Be Dumped appeared first on Investo...
Penny stocks to buy right now according to analysts. The post 5 Penny Stocks To Buy According To Analysts With Targets Up To 156% appeared first on Penny Stocks to Buy, Picks, News and Information | Pen...
PROG Stock IPOed in 2020 to develop a genetic testing business. Progenity has now shut that business down, leaving shareholders in a lurch.
Short squeeze penny stocks to watch right now. The post Best Penny Stocks To Buy?
5 Short Squeeze Candidates To Watch: Huadi Tops List, Altimeter Group And Bit Digital Rejoin Leaderboard
Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next GameStop Corp (NYSE:GME) or AMC Entertainment Holdings Inc (NYSE:AMC). A short squeeze can occur when...
SAN DIEGO, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced that the company will participate in a pre-recorded fireside chat at the...
Only a meme stock could garner the kind of investor interest PROG stock has with no chance of returning to 2020 revenue levels anytime soon. The post I Almost Confused Progenity With Progressive Insuran...
Progenity's plan to ditch most of its current portfolio and double down on R&D may come back to bite it later. Avoid PROG stock for now.
Progenity may be onto something big, but today it's just a meme stock. Following earnings, PROG stock is in trouble.